T2 Biosystms Dividends

TTOO Stock  USD 3.16  0.20  6.76%   
As of the 23rd of April 2024, Dividend Paid And Capex Coverage Ratio is likely to grow to 263.58. T2 Biosystms' past performance could be the main factor of why investors trade T2 Biosystms stock today. Investors should clearly understand every aspect of the T2 Biosystms dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest T2 Biosystms' dividend schedule and payout information. T2 Biosystms dividends can also provide a clue to the current valuation of T2 Biosystms.
Last ReportedProjected for Next Year
Dividends Paid 0.00  0.00 
Dividend Yield 0.00  0.00 
Dividend Payout Ratio 0.00  0.00 
Dividend Paid And Capex Coverage Ratio 251.03  263.58 
One of the primary advantages of investing in dividend-paying companies such as T2 Biosystms is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.
  
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in T2 Biosystms must own a stock before its ex-dividend date to receive its next dividend.

Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(19.19)
Revenue Per Share
2.756
Quarterly Revenue Growth
(0.69)
Return On Assets
(0.85)
Return On Equity
(6.22)
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Compare Dividends Across Peers

Specify up to 10 symbols: